Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Open Label, Controlled Study Evaluating the Effectiveness and Safety of Furoscix On-Body Infusor vs Continued Medical Therapy for Worsening Heart Failure

Next Previous
X
Search
Trial Profile

A Multicenter, Randomized, Open Label, Controlled Study Evaluating the Effectiveness and Safety of Furoscix On-Body Infusor vs Continued Medical Therapy for Worsening Heart Failure

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Furosemide (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms AT HOME-HF; AT HOME-HF PILOT
  • Sponsors scPharmaceuticals

    • Most Recent Events

    • 10 May 2023 According to a scPharmaceuticals media release, data from this study were presented at the Technology and Heart Failure Therapeutics Conference 2023.
    • 22 Mar 2023 According to a scPharmaceuticals media release, data from this study will be presented at the Technology and Heart Failure Therapeutics Conference, March 20-22, 2023.
    • 30 Sep 2022 According to scPharmaceuticals Media Release, results from this trial were presented at the Heart Failure Society of America (HFSA) 2022 Annual Meeting

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top